ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024

Real-World Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Mild-to-Moderate Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Retrospective, Single-Arm Clinical Trial [Letter].

Raúl Daniel Aguilar CastañedaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.